242 related articles for article (PubMed ID: 17880755)
1. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
Klausner HA; Brown P; Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB
Curr Med Res Opin; 2007 Nov; 23(11):2637-45. PubMed ID: 17880755
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB
Urology; 2008 Jan; 71(1):17-22. PubMed ID: 18242357
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.
Richard GA; Klimberg IN; Fowler CL; Callery-D'Amico S; Kim SS
Urology; 1998 Jul; 52(1):51-5. PubMed ID: 9671870
[TBL] [Abstract][Full Text] [Related]
4. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis.
Connolly LE; Riddle V; Cebrik D; Armstrong ES; Miller LG
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378708
[TBL] [Abstract][Full Text] [Related]
6. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
West M; Boulanger BR; Fogarty C; Tennenberg A; Wiesinger B; Oross M; Wu SC; Fowler C; Morgan N; Kahn JB
Clin Ther; 2003 Feb; 25(2):485-506. PubMed ID: 12749509
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Bundrick W; Heron SP; Ray P; Schiff WM; Tennenberg AM; Wiesinger BA; Wright PA; Wu SC; Zadeikis N; Kahn JB
Urology; 2003 Sep; 62(3):537-41. PubMed ID: 12946763
[TBL] [Abstract][Full Text] [Related]
9. 5-Day versus 10-Day Course of Fluoroquinolones in Outpatient Males with a Urinary Tract Infection (UTI).
Mospan GA; Wargo KA
J Am Board Fam Med; 2016 Nov; 29(6):654-662. PubMed ID: 28076247
[TBL] [Abstract][Full Text] [Related]
10. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
Wagenlehner FM; Umeh O; Steenbergen J; Yuan G; Darouiche RO
Lancet; 2015 May; 385(9981):1949-56. PubMed ID: 25931244
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Nicodemo AC; Robledo JA; Jasovich A; Neto W
Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
Huntington JA; Sakoulas G; Umeh O; Cloutier DJ; Steenbergen JN; Bliss C; Goldstein EJ
J Antimicrob Chemother; 2016 Jul; 71(7):2014-21. PubMed ID: 26994090
[TBL] [Abstract][Full Text] [Related]
14. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women.
Raz R; Naber KG; Raizenberg C; Rohana Y; Unamba-Oparah I; Korfman G; Yaniv I
Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):327-31. PubMed ID: 10898131
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
[TBL] [Abstract][Full Text] [Related]
18. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF
Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458
[TBL] [Abstract][Full Text] [Related]
19. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis.
Naber KG; Llorens L; Kaniga K; Kotey P; Hedrich D; Redman R
Antimicrob Agents Chemother; 2009 Sep; 53(9):3782-92. PubMed ID: 19581455
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
